Your browser doesn't support javascript.
loading
Neoadjuvant camrelizumab and chemotherapy in patients with resectable stage IIIA squamous non-small-cell lung cancer: Clinical experience of three cases.
Li, Xin; Xia, Chunqiu; Liu, Minghui; Liu, Jinghao; Dong, Ming; Zhao, Honglin; Xu, Song; Wang, Dan; Wei, Sen; Song, Zuoqing; Chen, Gang; Liu, Hongyu; Chen, Jun.
Afiliação
  • Li X; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Xia C; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Liu M; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Liu J; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Dong M; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Zhao H; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Xu S; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Wang D; Department of Pathology, Tianjin Medical University General Hospital, Tianjin, China.
  • Wei S; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Song Z; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Chen G; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Liu H; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China.
  • Chen J; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Front Oncol ; 12: 843116, 2022.
Article em En | MEDLINE | ID: mdl-36176413

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China